Search results
Results from the WOW.Com Content Network
In the United States, the use of cannabis for medical purposes is legal in 38 states, four out of five permanently inhabited U.S. territories, and the District of Columbia, as of March 2023. [1] Ten other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a ...
Legal to possess up to 8 oz (230 g), 1 oz (28 g) of concentrate, and 72 oz (2 kg) of edibles in a residence. Patients are able to possess up to 3 oz (85 g) in public. Legal only for medical patients up to an amount of six plants & 6 seedlings per person. [156] Main article: Cannabis in Oklahoma.
Medical cannabis can be administered through various methods, including capsules, lozenges, tinctures, dermal patches, oral or dermal sprays, cannabis edibles, and vaporizing or smoking dried buds. Synthetic cannabinoids are available for prescription use in some countries, such as synthetic delta-9-THC and nabilone.
"Among medical-only states, Florida continued its double-digit growth, adding an astonishing 324,400 medical marijuana patients in 2022 — bringing the state’s registered total to 781,000 ...
Outside of the Qualla Boundary, some low-THC products have been legalized in N.C. under a 2021 state law. The law allows the sale of products with no more than 0.3% of delta-9, allowing the sale ...
Recreational pot sales are nearing reality in Ohio. The state Division of Cannabis Control began accepting applications Friday for new dual licenses that will allow existing medical marijuana ...
In Colorado, cannabis has been legal for medical use since 2000 and for recreational use since late 2012. On November 7, 2000, 54% of Colorado voters approved Amendment 20, which amended the Stateonstitution to allow the use of marijuana in the state for approved patients with written medical consent. Under this law, patients may possess up to ...
The bill also fully removed or "descheduled" low-THC cannabis products from the Controlled Substances Act, where they had been listed as Schedule I drugs since the CSA's inception in 1970. [3] [11] 2022: The Medical Marijuana and Cannabidiol Research Expansion Act is signed into law to allow cannabis to be more easily researched for medical ...